Marihella James

Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study

Vadim S. Koshkin, Nicholas Henderson, Marihella James et al. · Cancer · 2021 · 85 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti–PD-1 Refractory Melanoma

Cara Haymaker, Daniel H. Johnson, Ravi Murthy et al. · Cancer Discovery · 2021 · 69 citations · Full text

Medicine, Oncology, Pharmacology +17

Pembrolizumab Plus Pegylated Interferon alfa-2b or Ipilimumab for Advanced Melanoma or Renal Cell Carcinoma: Dose-Finding Results from the Phase Ib KEYNOTE-029 Study

Michael B. Atkins, F. Stephen Hodi, John A. Thompson et al. · Clinical Cancer Research · 2018 · 56 citations

Pharmacy, Oncology, Pharmacotherapy +17

A phase II trial of recombinant MAGE-A3 protein with immunostimulant AS15 in combination with high-dose Interleukin-2 (HDIL2) induction therapy in metastatic melanoma

Jennifer L. McQuade, Jade Homsi, Carlos A. Torres‐Cabala et al. · BMC Cancer · 2018 · 39 citations · Full text

Pharmacy, Immunology, Oncology +17

A phase 2 study to evaluate the safety and efficacy of Intratumoral (IT) injection of the TLR9 agonist IMO-2125 (IMO) in combination with ipilimumab (ipi) in PD-1 inhibitor refractory melanoma.

Adi Diab, Shah Rahimian, Cara Haymaker et al. · Journal of Clinical Oncology · 2018 · 23 citations

Life Sciences, Immunology, Oncology +17